Vassalle C, Mercuri A, Maffei S. Oxidative status and cardiovascular risk in women: Keeping pink at heart. World J Cardiol 2009; 1(1): 26-30 [PMID: 21160573 DOI: 10.4330/wjc.v1.i1.26]
Corresponding Author of This Article
Dr. Cristina Vassalle, PhD, G. Monasterio Foundation & Institute of Clinical Physiology-CNR, Via Moruzzi 1, I-56124, Pisa, Italy. email@example.com
Article-Type of This Article
Guidelines For Clinical Practice
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Cristina Vassalle, Antonella Mercuri, Silvia Maffei, G. Monasterio Foundation & Institute of Clinical Physiology-CNR, I-56124, Pisa, Italy
Author contributions: Vassalle C has conceived and written the manuscript, including acquisition and analysis and interpretation of data available in literature; Mercuri A and Maffei S have critically revised the manuscript for important intellectual content.
Correspondence to: Dr. Cristina Vassalle, PhD, G. Monasterio Foundation & Institute of Clinical Physiology-CNR, Via Moruzzi 1, I-56124, Pisa, Italy. firstname.lastname@example.org
Telephone: +39-50-3152199 Fax: +39-50-3152166
Received: November 21, 2009 Revised: December 9, 2009 Accepted: December 14, 2009 Published online: December 31, 2009
Although cardiovascular disease (CVD) has always been perceived as a pathology regarding essentially males, incidence and death from cardiovascular events dramatically increase after menopause in women. Obviously, while many aspects of CVD are similar in both sexes, it is now clear that there are significant differences as well. Exploration of these gender-related differences in CVD might provide a basis for the development of new strategies in the management of patients with CVD from a gender point of view. In particular, a growing amount of data suggested the possible major role of oxidative stress in female patients and the possibility to integrate this new biomarker in future study evaluating CVD risk in women.